GENERIC NAME | This data is not available for free |
STRUCTURE |
4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl) phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino] benzamide |
INDICATION'S | Onco.>Leukemia>Myeloid>Chronic>Ph(+) |
MECHANISM OF ACTION | Bcr-Abl Tyrosine Kinase Inhibition |
STATUS | Approved in EU & USA |
UPDATE | 2017. 11.20 |
COMPANY | This data is not available for free |
PATENT NUMBER | This data is not available for free |
Want more information ? Interested in the hidden information ? Click here and do your request. |